ArticleFrontiers in pharmacology2023

The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator.

Varsha D Shiragannavar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.